NCT02169232

Brief Summary

Endotracheal intubation of the morbidly obese is often performed awake. Fiberoptic bronchoscope assisted endotracheal intubation, a commonly utilized technique for securing an airway while a patient is awake, has many limitations. The video laryngoscope is a device that is similar to a conventional laryngoscope but uses a video system to visualize the larynx. Because of its low cost, ease of use, and usefulness in the presence of edema or bleeding that may obstruct the airway, video assisted laryngoscopy has been shown to be useful for awake endotracheal intubations. However, a direct comparison of the fiberoptic bronchoscope with video assisted laryngoscopy has not been performed for awake endotracheal intubations in of obese patients. Patients undergoing laparoscopic gastric bypas andrecquiring awake intubations will be randomized for either fiberoptic bronchoscope or video assisted laryngoscopy. The investigators primary outcome will be the time required for successful intubation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 23, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

June 23, 2014

Status Verified

June 1, 2014

Enrollment Period

1 year

First QC Date

June 19, 2014

Last Update Submit

June 20, 2014

Conditions

Keywords

Awake intubationVideolaryngoscopeFiberoptic

Outcome Measures

Primary Outcomes (1)

  • The time required for successful intubation

    The time required for successful intubation, which will be measured as the time from which the bronchoscope or videolaryngoscope is initially introduced into the oropharynx, until the time that CO2 is registered on the capnogram.

    10 minutes

Secondary Outcomes (1)

  • Number of intubation attempts, defined as a complete withdrawal and re-insertion of the airway instrument.

    10 minutes

Other Outcomes (2)

  • The ease of intubation using a 10 cm visual analogue scale, completed both by the person performing the intubation, and an independent observer.

    one hour

  • Post-operatively the patient's satisfaction

    24 hours

Study Arms (2)

Videolaryngoscope

ACTIVE COMPARATOR

Intubation by videolaryngoscope

Device: Videolaryngoscope

Fiberoptic

ACTIVE COMPARATOR

Intubation by fibroscope

Device: Fiberoptic

Interventions

Also known as: Intubation by Glidoscope
Videolaryngoscope
Fiberoptic

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • morbidly obese patient presenting for bariatric surgery at the Royal Victoria Hospital

You may not qualify if:

  • moderate to severe systemic illness, i.e. American Society of Anesthesiologists (ASA) score of 4 or higher
  • inability to communicate in English or French
  • contraindications to the drugs used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Victoria Hospital

Montreal, Quebec, Canada

RECRUITING

MeSH Terms

Interventions

Optical Fibers

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and Supplies

Study Officials

  • Albert Moore, MD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Albert Moore, MD

CONTACT

Aly Elbahrawy, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

June 19, 2014

First Posted

June 23, 2014

Study Start

May 1, 2014

Primary Completion

May 1, 2015

Study Completion

December 1, 2015

Last Updated

June 23, 2014

Record last verified: 2014-06

Locations